$1.46-0.05 (-3.53%)
Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. in the Healthcare sector is trading at $1.48. The stock is currently near its 52-week low of $1.34, remaining 90.8% below its 200-day moving average. Technical signals show neutral RSI of 43 and bullish MACD crossover, explaining why APUS maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., I...